CYDY stock was $.94 cents on March 26 after the Vyera run that went to around a $1.50 level and had been sitting between 1.00 and $1.20 for 6 weeks before the COVID game started for us. I believe a lot more investors are now involved and the awareness of the multiple indications is now heightened, but the market thought the HIV potential was worth a buck.